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SUMMARY. A group general practice in Dublin’s inner city 
has had extensive experience of intravenous drug users since 
the late 1970s. Since 1985 a total of 54 human immunodefi-
ciency virus (HIV) seropositive patients have attended the 
practice, of whom 48 are intravenous drug users, four are the 
children of drug users and two have been infected through 
sexual contacts. Three patients have developed the acquired 
immune deficiency syndrome and at least eight have 
symptomatic HIV disease. Sixty per cent of Ireland’s 
seropositive population have been infected through 
intravenous drug abuse bur nationally only 16% of all 
intravenous drug users tested are seropositive; in the study 
practice, however, at least 35% (48/137) of known intravenous 
drug users are seropositive. 
through the intravenous use of drugs and this is similar to the 
situation in Edinburgh.5 In Ireland, homosexual or bisexual 
intercourse accounts for about 10% of the seropositive 
population whereas in the UK this is the route of infection for 
over 80% of the total.6 Heterosexual intercourse accounts for 
only a small number of seropositive individuals in Ireland. Of 
the 2701 intravenous drug users tested in Ireland, only 16% are 
seropositive; this is in marked contrast to Edinburgh where up 
to 50% of intravenous drug users tested are positive.5 It has 
been suggested that Ireland’s most serious problems with the 
acquired immune deficiency syndrome (AIDS) may result 
from intravenous drug users acting as a ‘bridge” for the virus 
into the non-drug using heterosexual population.7 
Method 
Since 1985 the study practice has kept a register of all patients 
who are found to be HIV seropositive when tested or who 
report a positive result to a test carried out elsewhere. 
Information was compiled from practice records on each of 
these individuals for the period October 1985 to May 1988. A 
separate register is kept of all those who are known to be 
current or past users of intravenous drugs. 
I
In
NTRAVENOUS heroin use has become a serious problem in 
Dublin’s inner city since the late 1970s. Those affected have 
mostly been young people with poor educational and 
employment records who live in local authority housing 
complexes.1 Although it has been estimated that as many as 
7000 people have used intravenous heroin since the late 1970s, 
there is evidence of a recent decline in the numbers of new 
users.2,3 Ireland’s intravenous drug problem is concentrated in 
Dublin and there is little evidence of a serious problem outside 
the city.1 
troduction 
Results 
Over the period 1978-88 the practice has dealt with 137 
intravenous drug users, of whom approximately 123 are felt to 
have been genuinely seeking help with their problems while 
the remainder attended on only one or two occasions and were 
intent solely on obtaining controlled drugs. Three of the 137 
drug users are known to have died. 
 The management of drug addiction in Dublin has centred 
on one drug advisory and treatment centre which offers 
detoxification, maintenance programmes and counselling. 
General practitioners are encouraged to refer patients to this 
centre for management of addiction but many drug using 
patients continue to attend their general practitioner with other 
problems. 
 The practice has dealt with 54 patients who are known to 
be HIV seropositive. This group includes 48 intravenous drug 
users (35% seroprevalence, 48/137), four children of 
intravenous drug users and two people who have been infected 
through sexual contacts. One of the latter two has been the 
regular sexual partner of an intravenous drug user, but has 
never used drugs and the other has had no contacts with drug 
users at any stage, but is in another high-risk group. Two of the 
intravenous drug users are known to have died, one by 
committing suicide shortly after the result of the HIV test was 
known and the other from drugs related causes. 
 The study practice is located in Dublin’s inner city and 
has a registered General Medical Service population of 3000 
and about 2000 private patients. There are two full-time 
doctors, two part-time doctors from the academic staff of the 
department of general practice at the Royal College of 
Surgeons in Ireland and a trainee. The practice has had 
extensive experience with a population of intravenous drug 
users since 1979.  Only six of the seroposilive intravenous drug users were 
known to the practice before they began to use drugs. The 
majority of the group attended the practice fairly regularly and 
only nine have made less than five visits (mean number of 
visits was 12). 
 Up to June 1988, 17534 tests for antibodies to the human 
immunodeficiency virus (HIV) had been carried out in Ireland 
and 742 individuals had been found to be seropositive.4 Sixty 
per cent of the seropositive population have been infected  
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 Table 1. Age and sex breakdown of the intravenous drug 
users and HIV seropositive patients. 
Number of patients  
Intravenous 
drug users 
(n = 137) 
HIV seropositive 
Patients 
(n = 54) 
Age (years) 
0-3 – 4 
4-17 – – 
18-25 56 23 
26-30 49 16 
31 + 32 11 
Sex 
Male 93 38 
Female 44 16 
n = total number of patients. 
 
noteworthy that the proportion of female intravenous drug 
users who are seropositive (12 out of 44, 27%) is considerably 
lower than the proportion of male users who are infected (36 
out of 93, 39%). Of the 54 patients who are HIV seropositive, 
50 are adults — 40 are single, six are married and four are 
separated; they have a total of 48 children. Eight of the 
children and 13 sexual partners are felt to be at high risk of 
infection with HIV but the practice has/no knowledge of tests 
being carried out. 
 In Dublin heroin abuse is a problem which affects specific 
highly vulnerable groups. Of the 54 seropositive individuals in 
this study, 29 have an infected relative, spouse or boy or 
girlfriend within the group; 34 patients have had a settled 
address in one of three local authority housing complexes 
nearby; and 37 family units are represented within the total of 
54 people. 
 Of the 48 seropositive intravenous drug users 12 began to 
use heroin before or during 1978; 28 began between 1979 and 
1982 and only four began between 1983 and 1985 (no 
information was available for the remaining four). It is thought 
that 21 are no longer using drugs by injection but that a further 
21 continue to inject (no information for the remaining six). 
 Three of the 54 seropositive patients have developed 
clinical characteristics of AIDS and one has been treated with 
and responded well to zidovudine. Eight others are known to 
have symptomatic HIV disease. Two patients are pregnant. 
 The year of testing and cumulative number of cases 
known to the practice are listed in Table 2. Tests for HIV 
seropositivity became available in October 1985. The test was 
carried out in the practice for nine patients, in prison for 13 and 
in hospital for 20 (no information for remaining 12 patients). 
While many patients informed the practice soon after their test 
was carried out in prison or hospital, others were not seen or 
did not volunteer the information for some time. Among the 54 
patients, 22 said that they received counselling before their test 
but, worryingly, 17 patients said they received no such 
counselling or were unable to remember any counselling (no 
information was available for the remaining 15 patients). 
Table 2. Year of HIV testing and the cumulative number of 
seropositive patients known to the practice. 
 Number of seropositive patients 
 Year of 
testing 
Practice aware 
(cumulative total)
1985 13 3 
1986 16 19 
1987 10 40 
1988 3 54 
No information 12 – 
Discussion 
This practice’s experience with HIV related problems is 
probably unique in general practice in Ireland. However, the 
practice itself is a normal group practice whose experience in 
the field has arisen because of its location and the practice’s 
policy of handling any problem which members of the local 
community may wish to bring along. 
 Intravenous drug users are seen in the same surgery 
sessions as other patients and can expect empathy and care for 
their problems, although prescriptions for controlled drugs are 
not issued. These are obtained when necessary from the drug 
advisory and treatment centre. The practice has not changed its 
policy towards drug users despite the increased prevalence of 
HIV related problems. 
 The number of HIV seropositive patients who have 
attended the practice reflects the severity of the area’s 
problems with intravenous drug abuse during the late 1970s 
and early 1980s. No generalizations can be made from this 
practice’s experience but other parts of Dublin, which have in 
the past reported serious local drug problems, may now have 
similar problems with HIV infection. 
 Although, nationally, only 16% of drug users who have 
been tested are HIV seropositive, in this practice at least 35% 
are seroposilive. As well as the many seropositive patients 
already attending, the practice is aware of many other 
intravenous drug users, spouses, partners and children who 
may also be infected. The dimensions of the problems which 
face families, carers medical services and other agencies in the 
area may therefore be significantly underestimated by the 
index cases reported here. 
 General practice has much to offer in the care of drug 
users.8 The unique relationship which exists between many 
general practitioners and their patients may be an important 
resource in educating and motivating those who are 
seropositive to reduce their high risk behaviour. However, 
evidence has shown that only about half of HIV seropositive 
patients attending hospital had informed their general 
practitioner of the diagnosis; although many felt that their 
general practitioner was not well informed about AIDS, many 
wished general practitioners could take a bigger part in their 
care.9 
 Sixty per cent of Ireland’s seropositive population have 
been infected through intravenous drug abuse. The roots of this 
problem lie not in medical but in social and environmental 
issues, such as unemployment, poor education, high density 
housing and young people who are vulnerable to the attractions 
of the drug using culture. The medical problems associated 
with AIDS should not divert attention from the fundamental 
non-medical issues from which intravenous drug abuse arises. 
 The practice policy on testing is to counsel anyone who 
requests an HIV test about the implications of a positive or 
negative result. Counselling must also assess the high risk 
behaviour of the patient and ensure that they understand how 
this behaviour places themselves and others at risk. It has been 
our experience that, after counselling, patients may postpone 
testing but may still modify their behaviour. It has been said 
that if a choice must be made between carrying out tests and 
counselling patients, then counselling is the more important 
activity.10 
 Intravenous drug users make up the bulk of both the 
practice’s and the nation’s population of HIV positive patients. 
Unlike other groups such as homosexuals and haemophiliacs, 
however, these people have virtually no opportunities or 
motivation to come together in self-help or support groups. In 
other high risk groups the existence of such structures seems to 
have played a role in containing the spread of HIV, so that 
intravenous drug users are one of the few high risk groups 
where HIV infection continues to increase. Society may have 
to recognize that the control of HIV spread and stopping 
intravenous drug abuse are separate problems which require 
separate solutions. Until recently the idea of teaching drug 
users to inject more safely was unacceptable but may now need 
to be considered carefully. 
 The issues of needle exchange, methadone maintenance 
and wider availability of condoms are controversial ones in 
Ireland at present. Until about three years ago condoms had 
limited availability in Dublin but are now available from a 
wide variety of outlets including family planning centres, 
pharmacies and some doctors’ surgeries. Recent reports from 
England and Scotland have indicated that needle exchange 
schemes are reasonably successful at attracting clients but less 
successful at keeping them.11 The view of the Department of 
Health is that each of these options may have limited value but 
must be implemented only as part of an overall programme for 
drug users and others at risk of AIDS. 
 The stigmas and possible Judicial implications of 
admitting to intravenous drug use have long been barriers 
which prevent users from seeking help, even from caring 
agencies. If such limitations are associated with efforts to 
educate and motivate drug users to change their high risk 
behaviour, then they are unlikely to succeed. Self help from 
within the drug using culture may have much to offer in 
controlling HIV and caring for those who are infected8 but 
must be encouraged and fostered before its value can be 
assessed. 
 The need for a variety of further research efforts is clear. 
This practice is already studying the workload and problems 
arising from both intravenous drug use and HIV seropositivity 
as weii as examining possible ways of reducing high risk 
behaviour. However, the need to undertake research on specific 
strategies for the care of those who are infected and for the 
prevention of further spread of the virus has been highlighted 
by the report of the Royal College of General Practitioner’s 
working party.12 This research must be initiated on a far wider 
scale than is possible in a single practice, 
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